v3.26.3
Organization and Principal Activities (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 02, 2026
Feb. 20, 2026
Feb. 03, 2026
Dec. 23, 2025
Apr. 30, 2026
Jan. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Organization and Principal Activities [Line Items]                
Date of incorporation             Jul. 16, 2021  
Gross proceeds             $ 248,000 $ 5,493,800
Aggregate fair value (in Dollars)               $ 4,854,929
Common Stock [Member]                
Organization and Principal Activities [Line Items]                
Shares issued [1]               82,000
Reverse stock split   1-for-20 1-for-20          
Aggregate fair value (in Dollars) [1]               $ 82
January 2026 Private Placement [Member]                
Organization and Principal Activities [Line Items]                
Shares issued           4,000,000    
Gross proceeds           $ 248,000    
Reverse stock split   1-for-20            
January 2026 Private Placement [Member] | Common Stock [Member]                
Organization and Principal Activities [Line Items]                
Shares issued           200,000    
Shanghai Sglcell Biotech Co., Ltd. [Member]                
Organization and Principal Activities [Line Items]                
Percentage of equity interest       100.00%        
Aggregate consideration amount       $ 23,000     $ 490,000  
Acellent Technologies [Member]                
Organization and Principal Activities [Line Items]                
Percentage of equity interest         100.00%      
Acellent Technologies [Member] | Common Stock [Member]                
Organization and Principal Activities [Line Items]                
Percentage of equity interest 100.00%              
Issued shares 270,000       270,000      
Securities Purchase Agreements [Member] | Common Stock [Member]                
Organization and Principal Activities [Line Items]                
Aggregate fair value (in Dollars)           $ 500,000    
[1] Giving retroactive effect to the 1-for-20 reverse stock split effected on February 20, 2026.